P20.01 MEVITEM: A European, randomized, open-label Phase...

Neuro-Oncology 2016 / 10 Vol. 18; Iss. suppl_4

P20.01 MEVITEM: A European, randomized, open-label Phase I/II study of vismodegib in combination with temozolomide versus temozolomide alone in adult patients with recurrent or refractory medulloblastoma presenting an activation of the Sonic Hedgehog pathway

Frappaz, D., Meyronnet, D., Garin, G., Laigle-Donadey, F., Le Rhun, E., Bonneville-Levard, A., Frenel, J., Idbaih, A., Gourmelon, C., Chinot, O.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/now188.287
Date:
October, 2016
File:
PDF, 44 KB
english, 2016
Conversion to is in progress
Conversion to is failed